Malaria during pregnancy constitutes a large health problem in areas of endemicity. The World Health Organization recommends that interventions are initiated at the first antenatal visit, and these improve pregnancy outcomes. This study evaluated fetal growth by ultrasonography and birth outcomes in women who were infected prior to the first antenatal visit (gestational age, <120 days) and not later in pregnancy. Compared with uninfected controls, women with early Plasmodium falciparum exposure had retarded intrauterine growth between gestational ages of 212 and 253 days (difference between means, 107 g [95% confidence interval {CI}, 26-188]; P = .0099) and a shorter pregnancy duration (difference between means, 6.6 days [95% CI, 1.0-112.5]; P = .0087). The birth weight (difference between means, 221 g [95% CI, 6-436]; P = .044) and the placental weight (difference between means, 84 g [95% CI, 18-150]; P = .013) at term were also reduced. The study suggests that early exposure to P. falciparum, which is not targeted for prevention by current control strategies, has a profound impact on fetal growth, pregnancy duration, and placental weight at term.
Pregnant women are particularly vulnerable to infection with
Plasmodium falciparum parasites, which can have serious impact on the mother, the fetus, and the newborn [1] . More than 50 million women are at risk every year, and the World Health Organization recommends that malaria-endemic countries operate prevention programs providing intermittent preventive treatment and insecticide-treated bed nets to pregnant women. These services are usually initiated at the first antenatal visit (ANV1). In many pregnant women, low-density P. falciparum infections often go unnoticed, as they do not cause overt clinical symptoms. Ample evidence has shown that these clinically silent infections cause maternal anemia, retardation in fetal growth and preterm delivery [2] [3] [4] [5] [6] .
The particular vulnerability of pregnant women is due to the parasites ability to accumulate in the intervillous space of the placenta [7] . As P. falciparum divides inside erythrocytes, the infected erythrocyte gets increasingly susceptible to being removed in the spleen. To prevent splenic passage, the parasite expresses P. falciparum erythrocyte membrane protein 1 (PfEMP1) on the surface of infected cells. PfEMP1 anchors infected erythrocytes to receptors on the vascular lining [8] . PfEMP1 constitutes a multiprotein family, and each parasite genome encodes around 60 different variants [9] . One of these variants, coded in all P. falciparum genomes, is VAR2CSA [10] . This protein binds infected erythrocytes to glycosaminoglycans expressed on the syncytiotrophoblast and present in the intervillous space [11, 12] .
The pathogenesis of placental malaria is not fully understood, but it is generally believed that the presence of infected erythrocytes provoke an inflammatory response, which, in turn, through a multitude of pathways, have negative effects on fetal growth [13] . The impact of malaria on birth outcome has mainly been based on classifying malaria exposure at term, either based on microscopy of peripheral or placental blood or by histological examination of placental biopsy specimens [14] . This allows assessment of the parasite burden at term and classification into past, chronic, or acute placental infection, but it does not allow evaluation of whether malaria parasite infections during early pregnancy constitute a health risk [15] . Recent longitudinal studies of pregnant women have indicated that malaria parasite infection early in pregnancy has a detrimental effect on the birth weight [16] [17] [18] [19] , whereas other studies have failed to detect statistically significant effects [20] [21] [22] [23] . A potential problem for these studies is that the grouping of women into those who had malaria parasite infection and controls without malaria parasite infection was based on the presence of parasites in peripheral blood at the time the women presented to the antenatal clinic.
Women who have had asymptomatic infections prior to this visit and spontaneously cleared the infection might thus have been misclassified.
In this study, parasite exposure was also determined using a serological marker of placental malaria. By comparing women exposed before ANV1 but not subsequently during pregnancy to women with no evidence of parasite exposure at any time during pregnancy, we show that early exposure to P. falciparum resulted in intrauterine growth retardation during the third trimester and a shorter pregnancy duration.
METHODS

Study Population and Follow-up
The study made use of information collected during STOPPAM, a longitudinal study of 995 pregnant women performed in Korogwe District, Tanzania [24] . Study participants were recruited among women seeking antenatal care. After enrollment, women attended 3 prescheduled ANVs at a gestational age of approximately 26 (ANV2), 30 (ANV3), and 36 (ANV4) weeks. Malaria transmission in this area has been holoendemic but declined dramatically during the study. In the current study (Figure 1 ), we selected women who were primigravidae or secundigravidae and had an estimated gestational age of <120 days at the first ANV, based on ultrasonography. These women were divided into those exposed to malaria and those not exposed to malaria before ANV1, based on whether blood slides or rapid diagnostic tests revealed parasites and/or they had plasma antibodies against VAR2CSA. To investigate the effect of malaria in early pregnancy, we excluded women with other pathologies, such as preeclampsia, and/or multiple pregnancies and those who gave birth to stillborn or newborns with congenital anomalies. Women who were blood smear positive for parasitemia or had a parasite-positive rapid diagnostic test after ANV1 and women with increasing plasma anti-VAR2CSA levels after ANV1 were also excluded. Thus, 28 and 93 pregnant women were characterized as exposed and nonexposed, respectively ( Table 1 ). The exact number of women and offspring that contributed to the different end points is available in Supplementary Tables 2-11. The study received ethical approval from the Tanzania Medical Research Coordinating Committee (NIMR/HQ/R.8a/Vol. IX/688). All participants gave informed written consent.
Malaria Diagnosis, Treatment, and Prevention
Venous blood specimens were collected in ethylenediaminetetraacetic acid-lined tubes at all visits and at delivery and were tested for malaria parasites, using a rapid diagnostic test. Women with a positive rapid diagnostic test result were treated with artemether-lumefantrine or quinine (first trimester infections or requiring hospital admission). Thick and thin blood smears were stained with Giemsa and examined by microscopy. Intermittent preventive treatment for malaria with sulfadoxine-pyrimethamine was administrated as directly observed treatment. The first dose was given in the second trimester after a gestational age of 20 weeks, and the second dose was administered in the third trimester, at least 4 weeks after the first dose.
Assessment of Fetal Growth and Gestational Age
Gestational age was estimated using crown-rump length or head circumference at ANV1. At ANV2, ANV3, and ANV4, fetal weight was estimated on the basis of head circumference, abdominal circumference, and femur length, according to the Hadlock algorithm [25] . Ultrasonography was performed using a 5-2 MHz abdominal probe. Details about ultrasonography have previously been published [24] . Estimated weights were converted to z scores, using a local sex-specific standard weight chart [24] . Fetal weight increases between ultrasonographies performed at ANV2-4 were calculated as [estimated weight at ANV n+1 ] -[estimated weight at ANV n ], where the estimated weight at ANV n+1 is calculated as [weight estimated by ultrasonography at ANV n+1 ] + [(mean gestational age for all women at ANV n+1 ) -(gestational age for the woman at ANV n+1 )] × {[(mean weight increase among all women between ANV n+1 and ANV n )/(mean GA of all women at ANV n+1 ) -[mean gestational age of all women at ANV n ]}, and the estimated weight at ANVn is the weight estimated for the woman at ANVn. The formula adjusts the estimated weight gain according to the interval between the 2 ultrasonography-based measurements by adjusting for the average weight gain per day in the cohort for the period in question. This was done because the exact interval between measurements differed a bit between the different women.
Measurement of Anti-VAR2CSA Antibodies
A recombinant protein encompassing the 6 extracellular domains of VAR2CSA was produced in insect cells [26] . Coupling to microplex beads and plex analysis were performed as described previously [27] . The individual immunoglobulin G (IgG) responses were quantified on the basis of the measured mean fluorescent intensity (MFI). The levels were reported as arbitrary units relative to a positive control plasma pool made with plasma from women with high plasma levels of anti-VAR2CSA antibodies. In the context, a 2-fold decrease in arbitrary units correspond to a 2-fold dilution of the positive control plasma. Individuals were classified as having an IgG response if the measured antibody level based on the MFI was higher than the mean MFI plus 2 SDs for 32 Danish controls. The cutoff corresponded to 1.692 arbitrary units.
Statistics
Statistical analyses were performed in Stata 14. For univariate analysis, the Student t test, the χ 2 test, and the Fisher exact test with 2-sided P values were used. For most outcome parameters, kernel density plots suggested that the data approached normal distribution. Since this was not the case for all outcomes (eg, fetal weight at ANV3) and because the number of observations in some cases was relatively low, we also performed Wilcoxon rank sum tests, the results of which are presented in Supplementary Tables 2-11. These tests yielded similar or lower P values in most tests.
Confounding factors were tested using simple linear regression and multivariate analyses. Confounding factors with a P value of ≤.2 in univariate tests were included in the multiple linear regression models. A stepwise backward elimination approach was used to obtain final models that included variables with a P value of ≤.1. Definition and selection of pregnant women with or without exposure to Plasmodium falciparum who were recruited at the first antenatal visit (ANV1) as part of the STOPPAM study (upper panels). B, Anti-VAR2CSA plasma immunoglobulin G (IgG) levels throughout pregnancy in 28 exposed women (lines) and 93 nonexposed women (Xs). The levels are reported as units relative to a positive control plasma pool. A 2-fold decrease in units correspond to a 2-fold dilution of the control plasma. AU, arbitrary units.
RESULTS
Patient Characteristics
We identified primigravid or secondigravid women who had a positive anti-VAR2CSA IgG titer or received a diagnosis of P. falciparum infection at ANV1 (Figure 1 ). VAR2CSA is the protein allowing P. falciparum to sequester in the placenta, and antibodies are developed as a consequence of placental infection [10, 28] . We excluded women who experienced P. falciparum exposure after ANV1 or had conditions known to affect pregnancy and enrolled 28 women classified as exposed before ANV1 (exposed) and 93 women (nonexposed) for whom there was no evidence of exposure to the parasite (Figure 1 ). Women were monitored at scheduled ANVs (Table 1 ). In addition, women could report spontaneously to be tested for malaria if they felt ill, and nonexposed women were slightly more likely to do so than exposed women (mean total number of visits with malaria testing, 5.9 vs 5.3; P = .02). The likelihood of only having a primary education level or lower was higher among exposed women (89% vs 70%; P = .05). Otherwise, the characteristics of the 2 groups of women did not differ statistically significantly at enrollment ( Table 1) .
Effect of Exposure on Maternal Hemoglobin Level and Fetal Growth
We first compared maternal hemoglobin levels at ANV1-4 and at delivery. The mean level was around 0.6 g/dL lower in the exposed group at ANV1 and ANV2, and the difference reached borderline statistical significance (Table 2 and Figure 2 ). There was no statistically significant difference between the groups at ANV3 and ANV4 or at the time of birth (Supplementary Table 1 ). Kernel density plots showing the distribution of hemoglobin levels within the groups indicated that the distribution (or shape of the curve) in the 2 groups was similar but with a slight shift to the left in the exposed population at ANV2 (Figure 2) .
We next compared the ultrasonography-based estimated fetal weight at ANV2-4 and the measured birth weight (Figure 2 ). The mean fetal weight was similar at ANV2 and ANV3 (Supplementary Table 1 ) but was lower in exposed women at ANV4 (difference between means, 121 g; 95% confidence interval [CI], 14-228; P = .027) and at birth (difference between means, 221 g; 95% CI, 6-436; P = .044; Table 2 ). Similarly, the mean z score was comparable between the groups at ANV2 and ANV3 and lower in exposed women at ANV4. There was no statistically significant difference between the z scores at birth ( Figure 2 , Table 2 , and Supplementary Table 1) . These results indicated that the main effect of parasite exposure was a reduction in fetal growth rate in late pregnancy. This was confirmed, as the mean fetal weight gain among exposed women between ANV3 and ANV4 was significantly less than that among nonexposed women (gestational age-adjusted difference between means, 107 g (95% CI, 26-188; P = .0099), with no apparent difference from ANV2 to ANV3 between the groups ( Figure 3 , Table 2 , and Supplementary Table 1 ).
Effect of Exposure on the Length of Pregnancy and Placental Weight
The birth weight was reduced among infants delivered by exposed women, but the z scores at birth were similar to those for infants delivered by nonexposed women, indicating that the weight reduction was connected to a shorter pregnancy period. This was indeed the case (Table 2 and Figure 3 ), since the mean gestational age at term was 279.4 days in nonexposed women, close to the average length of 280.6 days for normal pregnancies [29] , and 272.7 days in exposed women (difference between means, 6.6 days; 95% CI, 1.0-112.5; P = .0087). The observed effects of reduced fetal weight in the third trimester and shortened pregnancy length could be connected to inability of the placenta to support fetal growth. We thus compared the mean weight of placenta measured at birth between the exposed and nonexposed women. The mean placental weight was less in the exposed women (Figure 3 ), and the difference between means was 84 g (95% CI, 18-150; P = .013; Table 2 ).
Confounders and Explanatory Variables
Even though the characteristics of exposed and nonexposed women did not vary statistically significantly (Table 1) , confounding factors could influence the observed differences. As expected, all measures of fetal weight were associated with a measure of the mother's nutritional status at inclusion, but the effects of parasite exposure were largely retained in multiple linear regression models ( Table 2 ). The placental weight was associated with the gestational age at birth and gravidity, but parasite exposure remained as an explanatory variable in these models. These analyses indicated that the observed effects of early parasite exposure could not be explained by the tested confounding factors.
The study was designed to include women experiencing the first or second gravidity. To test whether the observed effects of early exposure differed according to gravidity, we performed secondary statistical analyses stratifying for this parameter. The conclusions were that parasite exposure mainly affected primigravidae, compared with secondigravidae, with regard to reduced gestational age at term (mean difference, 11 days [95% CI, 1-22; P = .0068] vs 4 days [95% CI, −3-11; P = .24]) and placental weight (mean difference, 151 g [95% CI, 49-254; P = .0068] and 45 g [95% CI, −40-131; P = .33]). The effects of exposure on fetal weight at ANV4, reduced weight gain between ANV3 and ANV4, and birth weight could not be assigned to gravidity. This was also the case for the borderline statistically significant effect of exposure on mother's hemoglobin level at ANV2 (Supplementary Table 7 ). Primigravid and secondigravid women were included in the study if the gestational age at inclusion (visit 1) was <120 days. To define exposure effects related to the first trimester of pregnancy only, we performed secondary statistical analyses that included women who were recruited before gestation day 97. This included 14 exposed and 46 nonexposed women. These tests could not show a statistically significant effect of parasite exposure on gestational age at delivery in women with an early inclusion, but they showed a statistically significant reduction in placental weight (difference between means, 100 g; 95% CI, 5-196; P = .040), fetal weight at ANV4 (difference between means, 159 g; 95% CI, 17-301; P = .029), z score at ANV4 (difference between means, 0.67; 95% CI, .09-13; P = .025), and mother's hemoglobin level at ANV2 (difference between means, 0.85 g/dL; 95% CI, .04-1.7; P = .039), compared with findings for nonexposed women who were recruited early. Women exposed before gestation day 97 had a decreased mean birth weight and decreased mean fetal weight gain between ANV3 and ANV4, but the differences did not reach statistical significance (difference between means, 191 g [95% CI, −88-470; P = .18] and 88 g [95% CI, −15-192; P = .093], respectively).
These analyses indicated that the effects of parasite exposure were seen both among primigravid and secondigravid women but were most pronounced in the primigravidae. The analyses also indicated that exposure to parasites before 97 days of Outcome measures in pregnant women with or without exposure to Plasmodium falciparum. Distribution (kernel density plots) of blood hemoglobin levels (top panels), weights of offspring (middle panels), and z scores (bottom panels) in exposed women (red curves) and nonexposed women (black curves). Data are from 3 antenatal care visits (ANV1-3) and at birth. The means and corresponding P values are shown in Table 2 or Supplementary Table 1 . GA, gestational age. gestation (13.7 weeks) also had profound effects on pregnancy and birth outcomes.
DISCUSSION
Detailed analysis of how malaria parasite infections early in pregnancy affect pregnancy outcomes is difficult to achieve. First, it requires that some women get exposed early in pregnancy and that women can be divided into exposed and nonexposed groups with reasonable certainty. Second, the malaria transmission risk should be moderate so that a sizeable proportion of women are likely not to get exposed to parasites later in pregnancy, as this would make it impossible to distinguish between the effects of early and late infections. Third, studies of this kind need to include a sizeable number of women undergoing repeat ultrasonography and must be able to record birth outcomes at health facilities.
Earlier studies have relied on methods to detect parasites or parasite protein at ANV1 to determine exposure status [16, 17, [20] [21] [22] [23] . This is not accurate, because women who have cleared infections or who have low-grade infections not detected by conventional diagnostic tests will be misclassified. We based the classification of exposure status on the detection of parasites, as well as on the presence of anti-VAR2CSA IgG, measured using a full-length recombinant VAR2CSA protein as a catching reagent. Since antibodies to VAR2CSA are induced by placental infections [10, 28, 30] , the exposure status is likely to be more precisely defined in this study as compared to earlier studies, but it is not perfect. Some women might have been Increase from ANV3 to ANV4, g P = .013 P = .021 Figure 3 . Outcome measures in pregnant women with or without exposure to Plasmodium falciparum. Distribution (kernel density plots) of weight gains between the specified antenatal visits (ANVs; top panels), gestational age at birth (bottom left panel), and placental weights (bottom right panel) in exposed women (red curves) and nonexposed women (black curves).
misclassified as nonexposed because of false-negative results of the IgG detection assay we used, and a few women classified as antibody positive might have had cross-reactive antibodies [31] . Similarly, some women might have had P. falciparum infections after ANV1 that remained undetected. We believe that this was a minor problem, because the women received intermittent preventive treatment and were tested for malaria parasite infection on numerous occasions during pregnancy, and those in whom there was serological evidence of malaria parasite infection were excluded from the analysis. On the basis of our strategy, 28 women were classified as exposed and 93 as nonexposed to P. falciparum prior to the 120th day of pregnancy. Even though the sample size was limited, we detected statistically significant, clinically relevant, and logically coherent effects of early parasite exposure. This included intrauterine growth retardation, which could not be detected in the months immediately after parasite exposure but only took effect about 3 months after the infection had cleared. Moreover, the mean pregnancy duration was nearly 1 week less in exposed women. In combination, the reduced fetal growth and preterm delivery resulted in a mean birth weight that was 221 g lower in exposed individuals. The fact that the effect of parasite exposure manifested itself several months after the parasites had been cleared-a finding that has been reported previously [18, 23, 32] -implies that early infection influences the ability of the placenta to support fetal growth, which cannot be explained by placental insufficiency caused by parasite sequestration and inflammation. A previous study with a limited sample size (4 women) suggested that P. falciparum infection prior to the 24th week of gestation was associated with a low placenta volume as measured by ultrasonography [33] . In line with this, we found that the mean placental weight at birth was 14% less for exposed women (difference between means, 84 g), compared with nonexposed women. We did not measure the placental volume by ultrasonography and thus cannot establish whether early infections have an immediate effect on placental volume. However, it is worth noting that small placental volume early in pregnancy is a predictor of intrauterine growth retardation at birth [34] . Small placental size has been linked to impaired trophoblast invasion, which in turn is linked to complications later in pregnancy, including preterm delivery [35] . The parasite molecule VAR2CSA, which anchors parasitized erythrocytes in the placenta, interacts with oligosaccharides motives that are expressed on proteins in the placenta and not on normal cells outside this organ [12, 36] . However, VAR2CSA binds to most tumor cells [36] and tumor cells that have bound VAR2CSA exhibit decreased migration, invasion, and growth [37] . It is thus not inconceivable that exposure to VAR2CSA could affect trophoblasts and lead to irreversible damage for the establishment of a proper uteroplacental circulation. The sample size limited the statistical power to detect differences in subgroups of exposed women. Nevertheless, there was a tendency that the effect of early exposure to P. falciparum, as could be expected, was most pronounced in primigravidae. Clear effects could be detected in women who had been exposed and developed anti-VAR2CSA antibodies before day 97 of gestation. Assuming that the induction of IgG takes 14 days, these women were exposed to parasites on around gestational day 80 or earlier. During placental development trophoblasts invade maternal spiral arteries and are exposed to maternal blood at 8 weeks of gestation [38] . A partial flow through the maternal fetal interface can be detected after gestation week 6 [39] and is established at 10-12 weeks (70-84 days), when the spinal arteriole plugs loosen [40] . VAR2CSA-expressing parasites can be isolated from pregnant women during the first trimester [41] , and it is not implausible that trophoblast exposure to VAR2CSA in the spiral arterioles could impede the ability of these cells to migrate and perform their crucial role in establishing the uteroplacental circulation. This would, as reported here, result in preterm delivery and intrauterine growth retardation [35] .
There is no doubt that the current World Health Organization policies to reduce the health impacts of P. falciparum infections during pregnancy save lives and reduce morbidity [42] . Every effort should be made to advance the implementation of these policies. It also remains extremely important to continue the focus on how best to use currently available antimalarial drugs and the research on development of new drugs for prevention of malaria during pregnancy. However, the findings presented here indicate that placental malaria will remain a major health problem in P. falciparum-endemic areas until women also can be protected during the first trimester. This will probably require development of a vaccine to prevent parasite sequestration in the placenta [43] or prevention of malaria exposure of all women of childbearing age.
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